Page 1257 - Small Animal Clinical Nutrition 5th Edition
P. 1257

INDEX 1309


                  Odontoclastic resorptive lesions, in cats, 982, 983b, 998-999c,  central vein infusion, 486-487
                    1010-1011                                           clinical importance, 477-478
                  Oils (See individual oils)                            compounding solutions for, 485-486, 486f
        VetBooks.ir  Oligosaccharides (See Fructooligosaccharide)       dextrose-fat ratios in solutions for, 481-483
                                                                        drug additions, 484t, 485, 485t
                  Olfactory physiology, 323-325
                  Omega-3 fatty acids (See Fatty acids)                 electrolyte solutions for, 484
                  Omega-6 fatty acids (See Fatty acids)                 energy solutions for, 480
                  Omnivore, dogs as omnivores, 252-253                  example calculations for cats, 479-480t
                  Onion toxicosis, 230t, 235, 372b, 435-436c            example calculations for dogs, 479-480t
                  Oral disorders (See Periodontal disease)              metabolic complications of, 491t
                  Oral rehydration solutions, 1055t                     monitoring parameters, 490-491
                  Orthopedic disease (See Developmental orthopedic disease  other routes of infusion, 488
                    and Osteoarthritis)                                 patient criteria for, 478t
                  Osmolality/osmolarity, of parenteral products, 480, 483, 483t,  peripheral vein infusion, 487-488
                    486-487                                             products for, 478-485, 481t,
                  Osteoarthritis, 695-713                               protein solutions for, 483-484
                    assessment of, 695-699, 697t, 700f                  risks and complications, 487b, 488-489,
                    clinical importance of, 695-699                     trace-element solutions for, 485
                    commercial foods for, 709t                          vitamin solutions for, 484-485
                    etiopathogenesis, 698-699                         Peanut hulls, 74f, 79t, 81t, 91t
                    feeding plan for, 707-711, 709f                   Pearson square, 12-14, 14f, 1121b
                    key nutritional factors for, 699-707, 701t        Pectin, 73, 74f
                    nutriceuticals, 704-706, 705b                     Pellicle (dental), 983
                    physical rehabilitation for, 708b                 Periodontal disease, 979-1001
                    risk factors for, 698                               assessment of, 980-982
                    use of fatty acids as treatment for, 700-704, 701f, 702f  chew toys, effects on, 994b, 998c
                  Osteochondritis dissecans (OCD) (See Osteochondrosis)  clinical importance of, 979
                  Osteochondrosis, 667-668, 668f, 672t, 675             clinical signs associated with, 987t
                  Otitis externa, association with adverse food reactions, 610,  etiopathogenesis of, 982-986, 985f
                    623-624                                             feeding plan for, 991-994
                  Ovariohysterectomy, effects of (See Neuter)           food forms, effects on, 986-989, 989f
                  Oxalate (See Calcium oxalate urolithiasis)            key nutritional factors for, 986-990
                                                                        prevalence of, 980
                  P                                                     risk factors for, 981-982
                  Palatability                                          stages of, 985f, 985t
                    factors affecting, 168-169                          systemic complications of, 984-985
                    enhancers, 170                                      treats, effects on, 992-993
                    of low-sodium foods, 754b,                        Perianal fistulas in dogs, dietary management of, 1119b
                    testing for palatability preference, 167-170      Pet food (Commercial pet foods), 157-190
                  Pancreatic enzyme preparations, 1140t                 acceptability/acceptance of food, 167-168
                  Pancreatic insufficiency (See Exocrine pancreatic insufficien-  addiction, 170
                    cy)                                                 additives, 176-177
                  Pancreatitis (acute and chronic), 1143-1153           digestibility of, 170-171
                    assessment of, 1143-1147                            dry (extruded),159-160
                    clinical importance of, 1143                        features and benefits of, 166
                    commercial foods for, 1149t, 1150t, 1151t           feeding costs of, 171
                    etiopathogenesis of, 1146-1147                      forms of, 158-161, 160f
                    feeding plan for patients with, 1148-1151           ingredient myths and facts, 173b
                    key nutritional factors for, 1147, 1147t            ingredients (commercial foods), 171-177
                    risk factors for, 1145-1146, 1145t                  labels (See Pet food labels)
                  Pantothenic acid, function, metabolism and sources of, 135-  marketing concepts for, 162
                    136                                                   all-purpose foods, 162
                    canine blood levels, 132t                             specific-purpose foods, 162
                    feline blood levels, 132t                           moist (canned), 158
                    requirements/deficiencies/excesses, 124t            preference testing of food, 167-168
                  Parathyroid hormone (See also Hyperparathyroidism), 670t,  segments, 165-166, 164f
                    772, 777f, 788f, 824-825t, 859t, 943                semi-moist, 160
                    association with developmental orthopedic disease of dogs,  shelf life of, 159, 175, 176, 182, 183, 184, 189-190
                    670, 670t                                           soft-dry, 160
                    association with urolithiasis, 873-874              temperature, effects on consumption, 169
                  Parenteral-assisted feeding, 477-498                  veterinary therapeutic foods, 166, 167b
                    administration of, 486-488                        Pet food labels, 191-206
   1252   1253   1254   1255   1256   1257   1258   1259   1260   1261   1262